News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
645,555 Results
Type
Article (44774)
Company Profile (131)
Press Release (600640)
Multimedia
Podcasts (95)
Webinars (22)
Section
Business (175717)
Career Advice (2577)
Deals (31425)
Drug Delivery (140)
Drug Development (76783)
Employer Resources (146)
FDA (14897)
Job Trends (13374)
News (305137)
Policy (29669)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (4)
Academia (2681)
Academic (1)
Accelerated approval (54)
Adcomms (35)
Allergies (176)
Alliances (43548)
ALS (219)
Alzheimer's disease (1842)
Antibody-drug conjugate (ADC) (503)
Approvals (15233)
Artificial intelligence (693)
Autoimmune disease (312)
Automation (55)
Bankruptcy (332)
Best Places to Work (10607)
BIOSECURE Act (21)
Biosimilars (233)
Biotechnology (90)
Bladder cancer (200)
Brain cancer (72)
Breast cancer (758)
Cancer (5993)
Cardiovascular disease (494)
Career advice (2201)
Career pathing (46)
CAR-T (337)
CDC (62)
Celiac Disease (1)
Cell therapy (921)
Cervical cancer (46)
Clinical research (67150)
Collaboration (2018)
Company closure (7)
Compensation (950)
Complete response letters (95)
COVID-19 (2707)
CRISPR (102)
C-suite (1221)
Cystic fibrosis (136)
Data (8137)
Decentralized trials (3)
Denatured (18)
Depression (177)
Dermatology (92)
Diabetes (606)
Diagnostics (6705)
Digital health (50)
Diversity (9)
Diversity, equity & inclusion (40)
Drug discovery (326)
Drug pricing (196)
Drug shortages (28)
Duchenne muscular dystrophy (298)
Earnings (72423)
Editorial (66)
Employer branding (21)
Employer resources (138)
Events (99099)
Executive appointments (1138)
FDA (18563)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (17)
Frontotemporal dementia (34)
Funding (1639)
Gene editing (227)
Generative AI (64)
Gene therapy (761)
GLP-1 (1073)
Government (4608)
Grass and pollen (7)
Guidances (412)
Healthcare (17456)
HIV (83)
Huntington's disease (59)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (110)
Immunology and inflammation (319)
Immuno-oncology (105)
Indications (187)
Infectious disease (3056)
Inflammatory bowel disease (220)
Inflation Reduction Act (13)
Influenza (132)
Intellectual property (288)
Interviews (542)
IPO (14347)
IRA (52)
Job creations (3047)
Job search strategy (1772)
JPM (57)
Kidney cancer (22)
Labor market (80)
Layoffs (560)
Leadership (49)
Legal (6736)
Liver cancer (104)
Longevity (30)
Lung cancer (828)
Lymphoma (438)
Machine learning (57)
Management (51)
Manufacturing (1039)
MASH (220)
Medical device (12066)
Medtech (12191)
Mergers & acquisitions (18249)
Metabolic disorders (1562)
mRNA (210)
Multiple sclerosis (191)
NASH (24)
Neurodegenerative disease (455)
Neuropsychiatric disorders (115)
Neuroscience (3430)
Neurotech (1)
NextGen: Class of 2026 (5927)
Non-profit (4237)
Now hiring (70)
Obesity (704)
Opinion (321)
Ovarian cancer (231)
Pain (253)
Pancreatic cancer (322)
Parkinson's disease (373)
Partnered (31)
Patents (586)
Patient recruitment (681)
Peanut (61)
People (57727)
Pharmaceutical (28)
Pharmacy benefit managers (22)
Phase 1 (20730)
Phase 2 (29452)
Phase 3 (22516)
Pipeline (9073)
Policy (336)
Postmarket research (2449)
Preclinical (8600)
Press Release (72)
Prostate cancer (312)
Psychedelics (63)
Radiopharmaceuticals (320)
Rare diseases (1115)
Real estate (5005)
Recruiting (61)
Regulatory (23768)
Reports (35)
Research institute (2307)
Resumes & cover letters (376)
Rett syndrome (39)
RNA editing (24)
RSV (82)
Schizophrenia (189)
Series A (279)
Series B (200)
Service/supplier (6)
Sickle cell disease (116)
Special edition (24)
Spinal muscular atrophy (170)
Sponsored (46)
Startups (3118)
State (2)
Stomach cancer (19)
Supply chain (118)
Tariffs (82)
The Weekly (75)
Vaccines (1103)
Venture capital (110)
Weight loss (468)
Women's health (107)
Worklife (21)
Date
Last 7 days (685)
Last 30 days (2728)
Last 365 days (28360)
2026 (13505)
2025 (28367)
2024 (32838)
2023 (36920)
2022 (47873)
2021 (51581)
2020 (49981)
2019 (42766)
2018 (32530)
2017 (29799)
2016 (28710)
2015 (33865)
2014 (26262)
2013 (21667)
2012 (22920)
2011 (24136)
2010 (21976)
Location
Africa (810)
Alabama (86)
Alaska (5)
Arizona (280)
Arkansas (14)
Asia (38816)
Australia (7559)
California (12263)
Canada (3698)
China (1402)
Colorado (504)
Connecticut (532)
Delaware (400)
Europe (86907)
Florida (1913)
Georgia (382)
Hawaii (1)
Idaho (62)
Illinois (1011)
India (94)
Indiana (542)
Iowa (19)
Japan (550)
Kansas (124)
Kentucky (46)
Louisiana (42)
Maine (80)
Maryland (1511)
Massachusetts (8736)
Michigan (366)
Minnesota (622)
Mississippi (6)
Missouri (149)
Montana (31)
Nebraska (26)
Nevada (136)
New Hampshire (80)
New Jersey (3423)
New Mexico (25)
New York (3234)
North Carolina (1556)
North Dakota (10)
Northern California (6131)
Ohio (357)
Oklahoma (20)
Oregon (33)
Pennsylvania (2434)
Puerto Rico (28)
Rhode Island (42)
South America (1088)
South Carolina (81)
South Dakota (2)
Southern California (4927)
Tennessee (189)
Texas (2027)
United States (43669)
Utah (390)
Vermont (1)
Virginia (320)
Washington D.C. (72)
Washington State (1021)
West Virginia (4)
Wisconsin (120)
Wyoming (2)
645,555 Results for "aravive biologics formerly known as ruga corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
TempraMed Signs Agreement for Exclusive Distribution Partnership in Brazil, One of the Largest Diabetes and Biologics Markets Globally
Expands Latin America presence with strategic partnership with Mobil Saúde and builds on TempraMed’s recently granted Brazilian patent portfolio Highlights: TempraMed signs Agreement for exclusive distribution in Brazil with Mobil Saúde Comercial Ltda Brazil represents one of the world’s largest markets for diabetes, GLP-1 therapies, and temperature-sensitive biologics1. Diabetes market alone reached USD $2.15 Billion in 2025 Partnership builds on TempraMed’s recently granted Brazilian patent protecting the VIVI Box™ platform Expands TempraMed’s commercialization footprint across Latin America following recent regional expansion initiatives
June 4, 2026
·
10 min read
Press Releases
Omios Biologics and XDemics Corporation Announce Strategic Collaboration to Revolutionize Oncolytic Virus Manufacturing and Accessibility
April 21, 2026
·
1 min read
Press Releases
ADMA Biologics Announces FDA Approval to Expand the Label for ASCENIV™ to Include Pediatric Immune Compromised Patients Two Years of Age and Older
May 4, 2026
·
6 min read
Sponsored
Cracking the Code: Solving Microbial Manufacturing’s Biggest Challenges
Perfecting microbial manufacturing processes means taming its greatest asset: speed. This rapid process for creating biologics also means a race against time, where success hinges on conquering three key challenges: designing a robust microbial strain, optimizing fermentation for industrial scale, and ensuring consistent high-yield product yield.
December 1, 2025
·
6 min read
·
AGC Biologics
Press Releases
NurExone Biologic Inc. Announces Fourth Quarter and Full-Year 2025 Financial Results and Provides Corporate Update
April 16, 2026
·
13 min read
Press Releases
REPATHA® CUTS RISK OF FIRST MAJOR CARDIOVASCULAR EVENTS BY 31% IN HIGH-RISK PATIENTS WITHOUT KNOWN SIGNIFICANT ATHEROSCLEROSIS
March 30, 2026
·
19 min read
Press Releases
Britannia Life Sciences Provides Corporate Update
Corporate Treasury Positioned with Cash and Liquid Equity Holdings to Seed, Incubate and Accelerate New and Existing Operations
May 21, 2026
·
4 min read
Press Releases
Recludix Pharma Announces Preclinical Data Demonstrating Efficacy Comparable to Monoclonal Antibodies Targeting IL-4/IL-13 Signaling Pathways and Differentiated Safety Profile of Oral STAT6 Inhibitor REX-8756 (also known as SAR448755) in a Model of Atopic Dermatitis
May 17, 2026
·
3 min read
Press Releases
BreezeBio (Formerly GenEdit) Announces Series B Financing to Advance Internal Pipeline of Precision Genetic Medicines
February 25, 2026
·
4 min read
Press Releases
Forge Biologics Announces Seven Presentations at the American Society of Gene and Cell Therapy (ASGCT) 29th Annual Meeting
May 11, 2026
·
3 min read
1 of 64,556
Next
